个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

Design, Synthesis, and Evaluation in Vitro of Quinoline-8-carboxamides, a New Class of Poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) Inhibitor.

  作者 Lord, Anna-Marie;Mahon, Mary F.;Lloyd, Matthew D.;Threadgill, Michael D.;  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2009年52-3;  页码  868-877  
  关联知识点  
 

[摘要]Poly(ADP-ribose)polymerase-1 is an important target enzyme in drug design; inhibitors have a wide variety of therapeutic activities. A series of quinoline-8-carboxamides was designed to maintain the required pharmacophore conformation through an intramol. hydrogen bond. 3-Substituted quinoline-8-carboxamides were synthesized by Pd-catalyzed couplings (Suzuki, Sonogashira, Stille) to 3-iodoquinoline-8-carboxamide, an efficient process that introduces diversity in the final step. 2-Substituted quinoline-8-carboxamides were prepd. by selective Pd-catalyzed couplings at the 2-position of 2,8-dibromoquinoline, followed by lithium-bromine exchange of the intermediate 2-(alkyl/aryl)-8-bromoquinolines and reaction with trimethylsilyl isocyanate. The intramol. hydrogen bond was confirmed by X-ray and by NMR. The SAR of the 3-substituted compds. for inhibition of human recombinant PARP-1 activity showed a requirement for a small narrow group. Substituents in the 2-position increased potency, with the most active 2-methylquinoline-8-carboxamide having IC50 = 500 nM (IC50 = 1.8 mM for 5-aminoisoquinolin-1-one (5-AIQ, a std. water-sol. inhibitor)).

 
      被申请数(1)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内